Safe Amgen's Dividend? A Practical Investor's Guide
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Timing matters: restructuring is best when income changes or spending diverges from goals.
16,677 articlesAmgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
A little-known corner of the market, rare earth stocks have moved in big swings. Here's how USA Rare Earth powered an...
A retiree with a $600,000 IRA defers claiming Social Security to age 70 to secure the 8% yearly boost. The strategy, ...
Today’s jump in the super micro computer stock surprised many, even as revenue guidance cooled. This article breaks d...
Two major crypto regulations dropping 2026 are on the horizon, touching stablecoins and market infrastructure. This g...
As markets navigate early-2026 volatility, three dividend-focused ETFs stand out for beginners. Low fees, broad diver...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...
Across software-as-a-service stocks, Wix has been a standout case of a dramatic pullback. This piece breaks down why ...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
A big-name investment fund backed an IoT stock with a $20 million stake last quarter. Since then, the stock has tumbl...
In March 2026, a disciplined approach to income investing means looking for companies with a proven track record of r...